Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis

Abstract Chronic inflammation plays an important role in the progression and outcome of chronic kidney disease (CKD). The circulating levels of the inflammatory biomarkers interleukin 6 (IL6) and pentraxin 3 (PTX3) are enhanced in CKD patients, and are associated with the progression of the disease...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Susana Rocha, Maria João Valente, Susana Coimbra, Cristina Catarino, Petronila Rocha-Pereira, José Gerardo Oliveira, José Madureira, João Carlos Fernandes, Maria do Sameiro-Faria, Vasco Miranda, Luís Belo, Alice Santos-Silva, Elsa Bronze-da-Rocha
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d51c922d9bdf4111aa14e097e7dd2729
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d51c922d9bdf4111aa14e097e7dd2729
record_format	dspace
spelling	oai:doaj.org-article:d51c922d9bdf4111aa14e097e7dd27292021-12-02T17:55:03ZInterleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis10.1038/s41598-021-94075-x2045-2322https://doaj.org/article/d51c922d9bdf4111aa14e097e7dd27292021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94075-xhttps://doaj.org/toc/2045-2322Abstract Chronic inflammation plays an important role in the progression and outcome of chronic kidney disease (CKD). The circulating levels of the inflammatory biomarkers interleukin 6 (IL6) and pentraxin 3 (PTX3) are enhanced in CKD patients, and are associated with the progression of the disease and with higher risk for cardiovascular events, the major cause of death in CKD patients. Our aim was to study how specific polymorphisms of IL6 and PTX3 encoding genes affect the inflammatory response and outcome of end-stage renal disease (ESRD) patients on dialysis. Methodology included the analysis of two single nucleotide polymorphisms (SNP), namely the IL6 (rs1800795) polymorphism in the promoter region (-174G > C), and the PTX3 (rs2305619) polymorphism in the intron 1 (+ 281A > G), which were analyzed in ESRD patients on dialysis and in a group of heathy individuals. The allelic frequencies, genotype distribution and their association with circulating levels of the inflammatory markers C-reactive protein (CRP), IL6, growth differentiation factor 15 (GDF15) and PTX3, were determined in ESRD patients. Events of death were recorded along one year, to assess the association of the studied SNPs with all-cause mortality and the inflammatory biomarkers, in ESRD patients. Results showed that the allelic frequencies and genotype distribution for IL6 and PTX3 SNPs in the control group and ESRD patients were similar and in agreement with other European reports. For the IL6 polymorphism, we found a trend towards higher levels of high-sensitivity (hs) CRP, IL6 and PTX3 in the homozygous genotypes; the CC genotype also showed the highest levels of GDF15. The mortality rate after the 1-year follow-up was 10.4%. The CC genotype (IL6 SNP) was associated to a higher risk of mortality and deceased patients carrying this genotype also showed the highest levels of hsCRP. Regarding the studied PTX3 SNP, the AA genotype was linked to an enhanced inflammatory response, showing the highest values of hsCRP and IL6. Nevertheless, this genotype had no significant impact on the mortality rate. In conclusion, both studied SNPs seem to modulate the inflammatory response in ESRD and may, therefore, be determinant on disease progression and patients’ outcome. Our data also highlights the importance of research on genetic variants that, although less frequent, may have significant biological value.Susana RochaMaria João ValenteSusana CoimbraCristina CatarinoPetronila Rocha-PereiraJosé Gerardo OliveiraJosé MadureiraJoão Carlos FernandesMaria do Sameiro-FariaVasco MirandaLuís BeloAlice Santos-SilvaElsa Bronze-da-RochaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Susana Rocha Maria João Valente Susana Coimbra Cristina Catarino Petronila Rocha-Pereira José Gerardo Oliveira José Madureira João Carlos Fernandes Maria do Sameiro-Faria Vasco Miranda Luís Belo Alice Santos-Silva Elsa Bronze-da-Rocha Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
description	Abstract Chronic inflammation plays an important role in the progression and outcome of chronic kidney disease (CKD). The circulating levels of the inflammatory biomarkers interleukin 6 (IL6) and pentraxin 3 (PTX3) are enhanced in CKD patients, and are associated with the progression of the disease and with higher risk for cardiovascular events, the major cause of death in CKD patients. Our aim was to study how specific polymorphisms of IL6 and PTX3 encoding genes affect the inflammatory response and outcome of end-stage renal disease (ESRD) patients on dialysis. Methodology included the analysis of two single nucleotide polymorphisms (SNP), namely the IL6 (rs1800795) polymorphism in the promoter region (-174G > C), and the PTX3 (rs2305619) polymorphism in the intron 1 (+ 281A > G), which were analyzed in ESRD patients on dialysis and in a group of heathy individuals. The allelic frequencies, genotype distribution and their association with circulating levels of the inflammatory markers C-reactive protein (CRP), IL6, growth differentiation factor 15 (GDF15) and PTX3, were determined in ESRD patients. Events of death were recorded along one year, to assess the association of the studied SNPs with all-cause mortality and the inflammatory biomarkers, in ESRD patients. Results showed that the allelic frequencies and genotype distribution for IL6 and PTX3 SNPs in the control group and ESRD patients were similar and in agreement with other European reports. For the IL6 polymorphism, we found a trend towards higher levels of high-sensitivity (hs) CRP, IL6 and PTX3 in the homozygous genotypes; the CC genotype also showed the highest levels of GDF15. The mortality rate after the 1-year follow-up was 10.4%. The CC genotype (IL6 SNP) was associated to a higher risk of mortality and deceased patients carrying this genotype also showed the highest levels of hsCRP. Regarding the studied PTX3 SNP, the AA genotype was linked to an enhanced inflammatory response, showing the highest values of hsCRP and IL6. Nevertheless, this genotype had no significant impact on the mortality rate. In conclusion, both studied SNPs seem to modulate the inflammatory response in ESRD and may, therefore, be determinant on disease progression and patients’ outcome. Our data also highlights the importance of research on genetic variants that, although less frequent, may have significant biological value.
format	article
author	Susana Rocha Maria João Valente Susana Coimbra Cristina Catarino Petronila Rocha-Pereira José Gerardo Oliveira José Madureira João Carlos Fernandes Maria do Sameiro-Faria Vasco Miranda Luís Belo Alice Santos-Silva Elsa Bronze-da-Rocha
author_facet	Susana Rocha Maria João Valente Susana Coimbra Cristina Catarino Petronila Rocha-Pereira José Gerardo Oliveira José Madureira João Carlos Fernandes Maria do Sameiro-Faria Vasco Miranda Luís Belo Alice Santos-Silva Elsa Bronze-da-Rocha
author_sort	Susana Rocha
title	Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
title_short	Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
title_full	Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
title_fullStr	Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
title_full_unstemmed	Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
title_sort	interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/d51c922d9bdf4111aa14e097e7dd2729
work_keys_str_mv	AT susanarocha interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT mariajoaovalente interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT susanacoimbra interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT cristinacatarino interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT petronilarochapereira interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT josegerardooliveira interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT josemadureira interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT joaocarlosfernandes interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT mariadosameirofaria interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT vascomiranda interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT luisbelo interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT alicesantossilva interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis AT elsabronzedarocha interleukin6rs1800795andpentraxin3rs2305619polymorphismsassociationwithinflammationandallcausemortalityinendstagerenaldiseasepatientsondialysis
_version_	1718379197869588480

Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis

Ejemplares similares